mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-06 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |